Journal article
In‐Office KTP Laser for Treating Hereditary Hemorrhagic Telangiectasia–Associated Epistaxis
Abstract
OBJECTIVE: To evaluated the efficacy and safety of in-office potassium titanyl phosphate (KTP) laser treatment for the management of epistaxis in hereditary hemorrhagic telangiectasia (HHT) patients.
METHODS: A retrospective case series of all HHT patients over age of 18 who underwent in-office KTP laser treatment from July 1, 2017 to December 31, 2019 was performed. The primary outcome measure was the epistaxis severity score (ESS) pre- and …
Authors
Wu V; Kell E; Faughnan ME; Lee JM
Journal
The Laryngoscope, Vol. 131, No. 3, pp. e689–e693
Publisher
Wiley
Publication Date
March 2021
DOI
10.1002/lary.28824
ISSN
0023-852X